Eflapegrastim Uses, Dosage, Side Effects and more
Eflapegrastim is under investigation in clinical trial NCT02953340 (Trial of SPI-2012 Versus Pegfilgrastim in the Management of Chemotherapy Induced Neutropenia in Early- Stage BReast Cancer Patients Receiving Docetaxel and Cyclophosphamide (RECOVER)).
| Attribute | Details |
|---|---|
| Trade Name | Eflapegrastim |
| Generic | Eflapegrastim |
| Eflapegrastim Other Names | Eflapegrastim |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
